Elevated Expression of a Regulator of the G2/M Phase of the Cell Cycle, Neuronal CIP-1-Associated Regulator of Cyclin B, in Alzheimer's Disease

Journal of Neuroscience Research

Volumn 75, Issue 5, 2004, Pages 698-703

  Zhu, Xiongwei ^a   McShea, Andrew ^b   Harris, Peggy L R ^a   Raina, Arun K ^a   Castellani, Rudy J ^c   Funk, Jens Oliver ^d   Shah, Sapan ^a   Atwood, Craig ^a,e   Bowen, Richard ^f   Bowser, Robert ^g   Morelli, Laura ^h   Perry, George ^a   Smith, Mark A ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b Combimatrix Corp ^*  (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^f Voyager Pharmaceutical Corporation   (United States)

^g UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^h UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Alzheimer's disease; Cell cycle; CIP 1 associated regulator of cyclin B cytoskeleton; Pathogenesis; Phosphorylation; Tau

Indexed keywords

CIP 1 ASSOCIATED REGULATOR OF CYCLIN B PROTEIN; CYCLIN B; CYCLIN DEPENDENT KINASE INHIBITOR 1; PROTEIN; PROTEIN P21; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CELL; BRAIN CORTEX; CELL CYCLE; CELL CYCLE G2 PHASE; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MITOSIS; NERVE CELL DEGENERATION; NEUROFIBRILLARY TANGLE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; TISSUE SECTION; TOPOGRAPHY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CARRIER PROTEINS; CELL CYCLE PROTEINS; CYCLIN B; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FEMALE; G2 PHASE; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; MITOSIS; NEOCORTEX; NERVE TISSUE PROTEINS; NEUROFIBRILLARY TANGLES; NEURONS; REFERENCE VALUES;

EID: 10744227217     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20028     Document Type: Article

References (34)

1. Arendt T, Rodel L, Gartner U, Holzer M. 1996. Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease. Neuroreport 7:3047-3049.
2. Bowen KL, Isley JP, Atkinson RL. 2000. An association of elevated serum gonadotropin concentrations and Alzheimer disease? J Neuroendocrinol 12:351-354.
3. Bowen RL, Smith MA, Harris PL, Kubat Z, Martins RN, Castellani RJ, Perry G, Atwood CS. 2002. Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology. J Neurosci Res 70:514-518.
4. Bowser R, Smith MA. 2002. Cell cycle proteins in Alzheimer's disease: plenty of wheels but no cycle. J Alzheimers Dis 4:249-254.
5. Braak H, Braak E. 1991. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82:239-259.
6. Busser J, Geldmacher DS, Herrup K. 1998. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. J Neurosci 18:2801-2807.
7. Engidawork E, Gulesserian T, Seidl R, Cairns N, Lubec G. 2001. Expression of apoptosis related proteins in brains of patients with Alzheimer's disease. Neurosci Lett 303:79-82.
8. Gomes WA, Kessler JA. 2001. Msx-2 and p21 mediate the pro-apoptotic but not the anti-proliferative effects of BMP4 on cultured sympathetic neuroblasts. Dev Biol 237:212-221.
9. Harris PL, Zhu X, Pamies C, Rottkamp CA, Ghanbari HA, McShea A, Feng Y, Ferris DK, Smith MA. 2000. Neuronal polo-like kinase in Alzheimer disease indicates cell cycle changes. Neurobiol Aging 21:837-841.
10. Israsena N, Kessler JA. 2002. Msx2 and p21(CIP1/WAF1) mediate the proapoptotic effects of bone morphogenetic protein-4 on ventricular zone progenitor cells. J Neurosci Res 69:803-809.
11. Khachaturian ZS. 1985. Diagnosis of Alzheimer's disease. Arch Neurol 42:1097-1105.
12. McShea A, Harris PL, Webster KR, Wahl AF, Smith MA. 1997. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. Am J Pathol 150:1933-1939.
13. McShea A, Wahl AF, Smith MA. 1999a. Re-entry into the cell cycle: a mechanism for neurodegeneration in Alzheimer disease. Med Hypoth 52:525-527.
14. McShea A, Zelasko DA, Gerst JL, Smith MA. 1999b. Signal transduction abnormalities in Alzheimer's disease: evidence of a pathogenic stimuli. Brain Res 815:237-242.
15. McShea A, Samuel T, Eppel JT, Galloway DA, Funk JO. 2000a. Identification of CIP-1-associated regulator of cyclin B (CARB), a novel p21-binding protein acting in the G2 phase of the cell cycle. J Biol Chem 275:23181-23186.
16. McShea A, Vincent I, Linford NJ, Smith MA, Dorsa DM, Shapiro RA. 2000b. Is Alzheimer's disease cancer of the neurons? Modeling oncogenic stimulation of primary neurons initiates Alzheimer's neuropathology. Soc Neurosci Abstr 26:2290.
17. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L. 1991. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479-486.
18. Nagy Z, Esiri MM, Cato AM, Smith AD. 1997. Cell cycle markers in the hippocampus in Alzheimer's disease. Acta Neuropathol 94:6-15.
19. Neaves WB, Johnson L, Porter JC, Parker CR Jr, Petty CS. 1984. Leydig cell numbers, daily sperm production, and serum gonadotropin levels in aging men. J Clin Endocrinol Metab 59:756-763.
20. Ogawa O, Lee HG, Zhu X, Raina A, Harris PL, Castellani RJ, Perry G, Smith MA. 2003a. Increased p27, an essential component of cell cycle control, in Alzheimer's disease. Aging Cell 2:105-110.
21. Ogawa O, Zhu X, Lee HG, Raina A, Obrenovich ME, Bowser R, Ghanbari HA, Castellani RJ, Perry G, Smith MA. 2003b. Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: a mitotic catastrophe? Acta Neuropathol 105:524-528.
22. Perry G, Roder H, Nunomura A, Takeda A, Friedlich AL, Zhu X, Raina AK, Holbrook N, Siedlak SL, Harris PL, Smith MA. 1999. Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation. Neuroreport 10:2411-2415.
23. Sternberger LA, Sternberger NH. 1986. The unlabeled antibody method: comparison of peroxidase-antiperoxidase with avidin-biotin complex by a new method of quantification. J Histochem Cytochem 34:599-605.
24. Vincent I, Rosado M, Davies P. 1996. Mitotic mechanisms in Alzheimer's disease? J Cell Biol 132:413-425.
25. Vincent I, Jicha G, Rosado M, Dickson DW. 1997. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J Neurosci 17:3588-3598.
26. Yang Y, Geldmacher DS, Herrup K. 2001. DNA replication precedes neuronal cell death in Alzheimer's disease. J Neurosci 21:2661-2668.
27. Yang Y, Mufson EJ, Herrup K. 2003. Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease. J Neurosci 23:2557-2563.
28. Zhu X, Raina AK, Smith MA. 1999. Cell cycle events in neurons. Proliferation or death? Am J Pathol 155:327-329.
29. Zhu X, Raina AK, Boux H, Simmons ZL, Takeda A, Smith MA. 2000a. Activation of oncogenic pathways in degenerating neurons in Alzheimer disease. Int J Dev Neurosci 18:433-437.
30. Zhu X, Rottkamp CA, Boux H, Takeda A, Perry G, Smith MA. 2000b. Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease. J Neuropathol Exp Neurol 59:880-888.
31. Zhu X, Rottkamp CA, Raina AK, Brewer GJ, Ghanbari HA, Boux H, Smith MA. 2000c. Neuronal CDK7 in hippocampus is related to aging and Alzheimer disease. Neurobiol Aging 21:807-813.
32. Zhu X, Castellani RJ, Takeda A, Nunomura A, Atwood CS, Perry G, Smith MA. 2001a. Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis. Mech Ageing Dev 123:39-46.
33. Zhu X, Raina AK, Rottkamp CA, Aliev G, Perry G, Boux H, Smith MA. 2001b. Activation and redistribution of c-Jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. J Neurochem 76:435-441.
34. Zhu X, Sun Z, Lee HG, Siedlak SL, Perry G, Smith MA. 2003. Distribution, levels, and activation of MEK1 in Alzheimer's disease. J Neurochem 86:136-142.